Global Burden of Cardiovascular Disease Global Efforts in Achieving 25 x 25

Similar documents
Global EHS Resource Center

Main developments in past 24 hours

Non communicable Diseases

Appendix F: Test-Curriculum Matching Analysis

WCPT COUNTRY PROFILE December 2017 JAPAN

Terms and Conditions. VISA Global Customer Assistance Services

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers

Injection Techniques Questionnaire (ITQ) WorldWide Results Needle Gauge

PMINJ Chapter May 4 th Symposium Straight-Up Emotional Intelligence

Field of Post-M.D. Training

Global Measles and Rubella Update November 2018

Injection Techniques Questionnaire (ITQ) WorldWide Results Insulin Usage

Country-wise and Item-wise Exports of Animal By Products Value Rs. Lakh Quantity in '000 Unit: Kgs Source: MoC Export Import Data Bank

Enriched RWE study in the Nordics a case study

Appendix F. The Test-Curriculum Matching Analysis Science TIMSS 2011 INTERNATIONAL RESULTS IN SCIENCE APPENDIX F 479

Global Measles and Rubella Update. April 2018

Why Non communicable Diseases? Why now?

THE GLOBAL HEALTH SECURITY AGENDA. We have to change our mindsets and start thinking about biological threats as the security threats that they are.

EU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 20 April 2017

Global Measles and Rubella Update October 2018

The Test-Curriculum Matching Analysis: Science

Tobacco: World Markets and Trade

Sperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ

UNITED NATIONS HIGH-LEVEL MEETING ON NCDs A CALL TO ACTION ON KIDNEY DISEASE. Advancing Nephrology Around the World

Current Trends in ODS Production and Supply

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist

Brigitte Khoury, Ph.D. Director, Arab Regional Center for Research, Training and Policy Making in Mental Health Dept. of Psychiatry, American

The Burden of Heart Failure in the Asia Pacific. Eugenio B. Reyes, M.D. Associate Professor, University of the Philippines, College of Medicine

WHO Health Statistics : Applied through the lens of the Global Monitoring Framework for the Prevention and Control of Noncommunicable Diseases

ESPEN Congress Geneva 2014 FOOD: THE FACTOR RESHAPING THE SIZE OF THE PLANET

The Global Tobacco Problem

Drug Prices Report Opioids Retail and wholesale prices * and purity levels,by drug, region and country or territory (prices expressed in US$ )

- Network for Excellence in Health Innovation

Promotion of Regulatory Cooperation Perspectives from the International Regulatory Cooperation for Herbal Medicines (IRCH)

New global report highlights silent epidemic of kidney disease and neglect of treatment and prevention in all countries

WHO global response to salt reduction strategies

WORLD HEALTH ORGANIZATION

World Connections Committee (WCC) Report

Report by the Convention Secretariat. Purpose of the document

Prohibition of importation, manufacturing and sale of Smokeless Tobacco products.

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers NZ & Australia

Palliative Care in Public Health System

CONNECTED HEALTH TRENDS

Monitoring EU Agri-Food Trade: Development until February 2018

THE CARE WE PROMISE FACTS AND FIGURES 2017

Hot Topics In Preparedness. Lessons Learned in Business Continuity

PCI in Asia Pacific Region. Angioplasty Summit TCT Asia Pacific th April 2006

of the Bone and Joint Decade The Global Challenge of Fragility Fractures and the Role of Fragility fracture Network

FACTS FIGURES A FUTURE

Advancing the Responsible Use of Medicines: Avoidable Costs and Considerations for Korea s Health System

Recipients of development assistance for health

AUSTRALIA. WCPT COUNTRY PROFILE December 2018

Prof. Tezer Kutluk, MD PhD, FAAP President Prevention Strategies in Cancer Union for International Cancer Control (UICC) 08 September 2016

ORBE Summary of Benefits

Sudden Cardiac Death

Global Variability in NCDs PURE

GLOBAL FMD SITUATION DURING 2001/2002

Recommended composition of influenza virus vaccines for use in the 2007 influenza season

The Global Health Security Agenda. Ambassador Bonnie Jenkins U.S. Department of State

Molecular Diagnostics Market Share, Size, Analysis, Growth, Trends and Forecasts, 2016 to 2024 Hexa Research

HPV Vaccines: Background and Current Status

World Health Organization Organisation mondiale de la Santé

Council Officers and Domain Chairs

3.1 PHASE 2 OF THE GLOBAL PROJECT

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?

Ferrari R, Fox K, Bertrand M, Mourad J.J, Akkerhuis KM, Van Vark L, Boersma E.

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2

The Global Summit of Women 2009 Santiago, Chile May 14-16

IMPLANTABLE MAGNETIC TRANSCUTANEOUS BONE CONDUCTION HEARING SYSTEM REIMBURSEMENT CODING GUIDE

ESMO ACROSS ONCOLOGY. WORLDWIDE. Josep Tabernero. ESMO President. ESMO SUMMIT MIDDLE EAST Friday, 6 th April 2018

Global Health Research Initiative (GHRI)

Update on progress of WBMT (Worldwide Network for Blood and Marrow Transplantation)

Investor Day Lausanne, June 21, André Calantzopoulos Chief Operating Officer Philip Morris International

The Global Impact of Dementia

Middle East Perspective on Burden of CVD. Hani Najm, MD, Msc, FACC Vice President of Saudi Heart Association

ANNUAL REPORT BKR International 2019

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.

There is no prevention. There is no cure.

Ethics education: global, inspiring and challenging

CND UNGASS FOLLOW UP

Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG-SAFE)

Commonwealth Secretariat

MSCI GLOBAL MARKET ACCESSIBILITY REVIEW JUNE Competitive landscape

Health outcomes & research objectives in (crosscultural)international

March of Dimes Global Programs. First Capability Workshop Trolleholm, Sweden 8 May 2007

ABC Global Alliance. F. Cardoso, MD

Asia s Diabetes Challenge

Role of UN Agencies in Achieving the Sustainable Development Goals (SDG 3.4)

POST SHOW REPORT. The Leading Dental Conference & Exhibition for Middle-East, Africa and South Asia markets.

XDR-TB Extensively Drug-Resistant Tuberculosis. What, Where, How and Action Steps

Drug-resistant Tuberculosis

ASIA-PACIFIC HEART HEALTH CHARTER

GLOBAL OUTLOOK ECONOMIC WATCH. March 2018

A Summary of Childhood Cancer Statistics in Australia,

First Fridays Webinar Series: Medical Education Group (MEG)

Multi-Country Opinion Research Survey TOPLINE RESULTS GLOBAL AVERAGE

HIV and Harm Reduction in Prisons

Brief Background on the March of Dimes Global Network for Maternal and Infant Health GNWIH)

Transcription:

Global Burden of Cardiovascular Disease Global Efforts in Achieving 25 x 25 William A. Zoghbi MD, MACC Elkins Family Distinguished Chair in Cardiac Health Professor and Chairmen, Department of Cardiology Houston Methodist DeBakey Heart & Vascular Center Houston, Texas

Distribution of Major Causes of Death Worldwide

Non Communicable Disease A Burden on the Developed and Developing World

Mortality Rates from Ischemic Heart Disease Age Standardized/100,000

Burden of Cardiovascular Disease DALYs, Age Standardized/100,000

An Urgent Development Issue NCDs make the largest contribution to mortality both globally and in the majority of low- and middle- income countries (LMICs) Worldwide, NCDs account for 60% (35 million) of global deaths The largest burden - 80% (28 million) - occurs in LMICs, making NCDs a major cause of poverty and an urgent development issue

Global Increase in CV Diseases Impact NCDs will cost the world $47 trillion over the next 20 years Of this, heart disease represents 43% or $20 trillion Sources: WEF, Harvard U & WHO

Deaths per 100,000 population Trends in CV Mortality in the US 600 500 400 300 200 100 1958 Coronary arteriography 1954 First open-heart procedure 1961 Risk factors 1961 Coronary care unit 1962 betablocker 1969 First CABG 1972 NHBPEP 1976 HMG CoA reductase inhibitor 1979 Coronary angioplasty 1980 First ICD 1983 CASS 1985 TIMI 1 1985 NCEP 1986 GISSI and ISIS-2 1992 SAVE 1993 Superiority of primary PCI in acute MI 2002 drug-eluting vs bare-metal stents 2002 ALLHAT 2007 CRT 2009 LVAD 2009 Genomewide association in early- MI 2009 gene sequencing for responsiveness to cardiovascular drugs 0 1950 1960 1970 1980 1990 2000 2010 2020 Year Nabel E and Braunwald G N Engl J Med 2012;366:54

Age-Standardized Death Rates by Sex and Cause of Death in the United States, 1969-2013. 3% per year 2.5% per year Source: Ma J, Ward EM, Siegel RL, Jemal A. Temporal trends in mortality in the United States, 1969-2013. JAMA. 2015;314(16):1731

Projected Mortality Trends NCD, Cardiovascular & Communicable Diseases

Global distribution of the physician workforce (per 10,000 population), 2000-2009 Source: World Health Statistics - 2010, World Health Organization, 2010.

Prevalence of Daily Tobacco Smoking in Males Age Standardized Adjusted

Tobacco and the Global NCD Epidemic Tobacco use kills 15,000 people a day around the world and second hand smoke exposure kills another 1,000. 70% of tobacco deaths occur in developing and middle-income countries, where tobacco use continues to rise. Source: NCD Alliance (2011) The FCTC and evidence-based tool to reduce the burden of disease

Ranking of 10 Selected Risk Factors of Cause of Death

Global Advocacy United Nations Summit on Non-Communicable Diseases First ever UN High Level Meeting on NCDs, September 2011 Second UN Summit on Health after AIDS summit in 2001 CV disease Voice: ACC,AHA,WHF Political declaration to establish targets for NCDs

Political Declaration Outcome of Summit: Political Declaration that detailed the global strategy for combatting NCDs Called on the WHO to establish global targets for combatting NCDs during 2012

World Health Assembly 2012 Approved Goal: 25% reduction in premature NCD mortality by 2025

September, 2012

WHO Meeting Geneva 2013

Simultaneously In JACC, Circulation, EHJ and Global Heart Sept 22, 2014

2030 Agenda By 2030, reduce by 1/3 premature mortality from NCDs through prevention and treatment Achieve Universal health Coverage September 2015

Can 25x25 be Achieved? Impact of Reduction of 6 Risk Factors on Mortality from NCDs Kontis V et al Lancet 384: 427, 2014

Impact of Reduction of 6 Risk Factors on Mortality from NCDs Kontis V et al Lancet 384: 427, 2014

Circulation & Global Heart, May 2016

Global Probability of Premature CV Death Effect of Risk factors Modification Men Women Circulation & Global Heart, May 2016

Regional Probability of Premature CV Death Effect of Risk factors Modification High Income Countries Eastern Europe/Central Asia Middle East/North Africa Circulation & Global Heart, May 2016

Probability of 30% reduction in tobacco use by 2025 Source: Bilano V, Gilmour S, Moffiet T, et al. Global trends and projections for tobacco use, 1990 2025: an analysis of smoking indicators from the WHO Comprehensive Information Systems for Tobacco Control. The Lancet.385(9972):966-976.

Average Physical Activity (MET-hours/week) United States India Gaziano TA. Boston, MA.. 2004. Adapted from: Murray CJL, Lopez Brazil AD, eds. The global burden of disease. Cambridge, MA: Harvard School of Public China Health; 1996. Source: Ng et al Obesity Reviews 2013; 13

Mean age-standardized sodium intakes (g/day) in 1990 and 2010 Powles J, BMJ Open. 2013;3(12).

Use of Secondary Meds by Country income (%) Source: Yusuf, S., Islam, S., Chow, C. K., Rangarajan, S., Dagenais, G., Diaz, R., Teo, K. K. (2011). Lancet 378(9798), 1231 43.

NCD Agenda Is Core To Sustainable Development Source: NCD Alliance

How Can Health Care Professionals & CV Societies Contribute?

ACC International Presence & Activities

ACC s 38 International Chapters African Consortium Argentina Australia Bangladesh Brazil Canada Caribbean Central American Consortium Chile China Colombia Dominican Republic Egypt Germany Great Britain and Ireland Greece and Cyprus Hong Kong Indonesia Israel Istanbul Consortium Italy Japan Jordan Korea Lebanon Malaysia Mexico Pakistan Peru Philippines Saudi Arabia Serbia & Republic of Srpska Singapore Spain Taiwan Thailand United Arab Emirates Venezuela

International Membership Growth 18000 16000 14000 12000 10000 8000 6000 4000 2000 0

Educational Programs 31 Programs Around the World reaching >30,000 cardiologists annually Bangladesh Brazil Chile China India Japan Mexico Nepal Oman Saudi Arabia UAE

Train the Trainer A top down teaching program with far reach and exponential growth ACC will train 50 KOLs who will then deliver content to 3,500 physicians around the China Train the Trainer in China 2013-2015

Fellows in Training (FIT) Programs Mexico February 2015 India October 2015

ACC Global Program on CVD Prevention An international comprehensive cardiovascular disease prevention curriculum that provides education and awareness to physicians/health care professionals throughout each participating country by: Partnering with ACC s local chapter to implement a three-part webinar series per year on cardiovascular disease prevention strategies and tools from prominent hospitals to a network of hundreds of health care institutions throughout the country Topic-based, interactive online education for cardiologists and cardiac care team members delivered through popular social media platforms

Global Program on CVD Prevention A Quick Snapshot of the China program 83% of participants satisfied or very satisfied with webinar education 3,378 physicians reached Broadcast to 342 hospitals 85% attended online, 15% in the live audience

Global Program on CVD Prevention Expanding in 2017 to the following countries: Russia UAE Saudi Arabia Egypt Mexico Argentina Vietnam Indonesia Malaysia

NCDR: A Global Initiative Assessing Quality

NCDR Global Footprint AUSTRALIA Queensland Paediatric Cardiac Service BAHRAIN Mohammed Bin Khalifa Cardiac Centre BRAZIL Complexo Hospitalar De Niteroi HCOR - Hospital Do Coracao Hospital Israelita Albert Einstein Hospital totalcor CANADA St. Paul's Hospital The Hospital For Sick Children PAKISTAN Tabba Heart Institute SAUDI ARABIA King Abdulaziz Medical City THAILAND Bangkok Heart Hospital UAE Dubai Health Authority

2016

It is Essential to Engage with the Community & Promote CV Health Learn When To Listen To Your Heart: Signs, Symptoms and Risk Factors of Heart Disease

International Leadership Academy at ACC Growing Emerging Leaders

The Road Towards Achieving 25 x 25 Significant reduction in CV Risk factors, morbidity and mortality is achievable; It is regional, local, and difficult. It is multifactorial: aim at risk factor modification and availability of both treatments and policies to reduce CVD mortality Policy interventions will likely include a focus on tobacco and salt reduction Needs resources! Countries will need to improve access to medications and develop health systems that are capable of managing acute and chronic conditions Need champions and emerging leaders of health in government, community, and in the CV profession Professional societies can help partner for health (community, government, industry), educate health professionals and groom emerging leaders